These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30066093)

  • 1. Thrombophilia Associated with Early Post-angioplasty Thrombosis of Dialysis Vascular Access.
    Chen TY; Lin L; Hsieh MY; Chen CH; Chen MK; Wu CC
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1683-1690. PubMed ID: 30066093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of thrombophilic risk factors on vascular access survival in chronic dialysis patients in a retrospective evaluation.
    Klamroth R; Orlovic M; Fritsche I; Seibt S; Seibt F; Wegscheider K; Landgraf H
    Vasa; 2013 Jan; 42(1):32-9. PubMed ID: 23385224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
    Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
    J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.
    LeSar CJ; Merrick HW; Smith MR
    J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia.
    Fekih-Mrissa N; Klai S; Bafoun A; Nciri B; Hmida J; Gritli N
    Ther Apher Dial; 2011 Feb; 15(1):40-3. PubMed ID: 21272251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.
    Shafi ST; Gupta M
    J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up.
    Grupp C; Troche-Polzien I; Stock J; Bramlage C; Müller GA; Koziolek M
    PLoS One; 2019; 14(9):e0222102. PubMed ID: 31539375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postintervention Patency: A Comparison of Stenting versus Patch Angioplasty for Dysfunctional Hemodialysis Access Sites.
    Trinh KN; Wilson SE; Gordon IL; Williams RA
    Ann Vasc Surg; 2016 May; 33():120-5. PubMed ID: 26965804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.
    Bakken AM; Protack CD; Saad WE; Lee DE; Waldman DL; Davies MG
    J Vasc Surg; 2007 Apr; 45(4):776-83. PubMed ID: 17398386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of efficacy of endovascular versus surgical repair for the treatment of arteriovenous fistula stenosis in Taiwan.
    Fan SS; Chen CW; Lu KC; Mao HC; Chen MP; Chou CL
    J Vasc Access; 2017 May; 18(3):200-206. PubMed ID: 28218365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy.
    Kakisis JD; Avgerinos E; Giannakopoulos T; Moulakakis K; Papapetrou A; Liapis CD
    J Vasc Surg; 2012 Feb; 55(2):472-8. PubMed ID: 22178435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention.
    Hasuike Y; Kakita N; Aichi M; Masachika S; Kantou M; Ikeda Takahashi S; Nanami M; Nagasawa Y; Kuragano T; Nakanishi T
    J Vasc Surg; 2019 Jan; 69(1):174-180.e2. PubMed ID: 29914835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transluminal angioplasty for central venous disease in dialysis patients: influence on cardiac function.
    Banshodani M; Kawanishi H; Shintaku S; Moriishi M; Yamashita T; Ago R; Sato T; Tsuchiya S
    J Vasc Access; 2014; 15(6):492-7. PubMed ID: 25041916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis.
    Gültekin F; Alagözlü H; Candan F; Nadir I; Bakici MZ; Sezer H
    ASAIO J; 2005; 51(2):162-4. PubMed ID: 15839442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients.
    Molino D; De Santo NG; Marotta R; Anastasio P; Mosavat M; De Lucia D
    Semin Nephrol; 2004 Sep; 24(5):495-501. PubMed ID: 15490419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty.
    Aftab SA; Tay KH; Irani FG; Gong Lo RH; Gogna A; Haaland B; Tan SG; Chng SP; Pasupathy S; Choong HL; Tan BS
    J Vasc Interv Radiol; 2014 Feb; 25(2):190-8. PubMed ID: 24315548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population - results from FLAER-based flowcytometry screening.
    Ahluwalia J; Naseem S; Sachdeva MU; Bose P; Bose SK; Kumar N; Thapa BR; Varma N; Chawla YK
    Eur J Haematol; 2014; 92(5):435-43. PubMed ID: 24400962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of SMART stent placement for arteriovenous graft salvage versus successful graft PTA.
    Vogel PM; Parise C
    J Vasc Interv Radiol; 2005 Dec; 16(12):1619-26. PubMed ID: 16371528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia.
    Azboy D; Temiztürk Z
    Heart Surg Forum; 2020 Oct; 23(6):E718-E724. PubMed ID: 33234223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.